Circulating tumor cells in HER2-positive metastatic breast cancer patients: A valuable prognostic and predictive biomarker
Số trang: 8
Loại file: pdf
Dung lượng: 834.09 KB
Lượt xem: 7
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
This study was initiated to investigate the prognostic significance of circulating tumor cell (CTC) enumeration and the predictive value of CTC HER2 expression for efficient anti-HER2 therapy in HER2-positive metastatic breast cancer (MBC) patients.
Nội dung trích xuất từ tài liệu:
Circulating tumor cells in HER2-positive metastatic breast cancer patients: A valuable prognostic and predictive biomarker
Nội dung trích xuất từ tài liệu:
Circulating tumor cells in HER2-positive metastatic breast cancer patients: A valuable prognostic and predictive biomarker
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Human epidermal growth factor receptor 2 Circulating tumor cell Anti-HER2 therapy HER2-positive metastatic breast cancerGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 169 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 139 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 109 0 0 -
12 trang 87 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 35 0 0
-
11 trang 35 0 0
-
12 trang 33 0 0